Schrader Andres Jan, Steffens Sandra
Department of Urology, Ulm University Medical Center, Prittwitzstrasse 43, 89075 Ulm, Germany.
ISRN Urol. 2012;2012:748235. doi: 10.5402/2012/748235. Epub 2012 Jun 10.
Renal cell carcinoma (RCC) is one of the most important urologic malignancies with a continuously growing incidence and health economic relevance. In 2011, several hundred articles, abstracts, and lectures have been presented at the leading global urooncologic congresses. This review was composed to give an overview on the flood of novel findings dealing with diagnostics and therapy of both localized and advanced RCC. The most clinically relevant data are discussed in detail.
肾细胞癌（RCC）是最重要的泌尿系统恶性肿瘤之一，其发病率持续上升，在健康经济方面的影响也日益显著。2011年，全球领先的泌尿肿瘤学大会上发表了数百篇文章、摘要和演讲。本综述旨在对有关局限性和晚期肾细胞癌诊断与治疗的大量新发现进行概述。文中详细讨论了最具临床相关性的数据。
